Understanding How Medication is Stored in the Home

NCT03894306 | Withdrawn

• 1 other identifier: 18-01297
• Study Type: observational
• Target: N/A
• Locations: 0 countries
• Sites: N/A

Brief Summary

The goal of this study is to increase safe medication storage practices in homes with young children in order to prevent unintentional childhood poisonings. As a step toward meeting this goal, this study aims to determine if an intervention to promote safe storage to patients who have young children in their home, including provision of a lock box or lock bag along with brief counseling versus brief counseling alone, results in 1) increased locked storage (and overall safe medication storage practices) of high-risk prescription medications in the home; 2) increased safe medication storage practices of other medications in the home; and 3) improved safe medication storage related knowledge and attitudes.

Conditions

Poisoning

Outcome Measures

Primary Outcomes (1)

• Percentage of patients with locked storage of all high-risk prescription medications at one month follow-up.

  1 Months

Study Arms (3)

medication lock box + brief counseling

Other: Medication lock box; Other: brief counseling

medication lock bag + brief counseling

Other: medication lock bag; Other: brief counseling

brief counseling alone

Other: brief counseling

Interventions

Medication lock box OTHER

given a lock box and instructed on how to use the device.

medication lock box + brief counseling

medication lock bag OTHER

given a lock bag and instructed on how to use the device.

medication lock bag + brief counseling

brief counseling OTHER

After completing the per-intervention survey, a research assistant or investigator will perform brief counseling, including educational handouts and information on safe medication storage

brief counseling alone; medication lock bag + brief counseling; medication lock box + brief counseling

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Adult patients in the buprenorphine clinic, high A1c clinic, or palliative care clinics at NYC Health + Hospitals/Bellevue who are prescribed at least one high-risk medication and have a child less than six years old present in his/her home on average at least 8 hours per week.

You may qualify if:

• Patient in the buprenorphine clinic, high A1c clinic, or palliative care clinic at NYC Health + Hospitals/Bellevue
• Patient prescribed at least one high-risk mediation. A high-risk medication defined as a prescription medication that may cause significant toxicity or death with the ingestion of only one pill or a single adult dose.
• A child less than six years old is present in the patient's home on average at least 8 hours per week.

You may not qualify if:

• Inability to speak and read English or Spanish
• No phone number for follow-up or unwilling to do follow-up by phone or in person
• Prior enrollment
• Patient was involved in pilot study

Sponsors & Collaborators

• NYU Langone Health: lead

MeSH Terms

Conditions

Poisoning

Condition Hierarchy (Ancestors)

Chemically-Induced Disorders

Study Officials

• Mark K Su, MD

  NYU Langone Health - Toxicology

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: March 26, 2019
• First Posted: March 28, 2019
• Study Start: June 1, 2021
• Primary Completion: June 1, 2022
• Study Completion: June 1, 2022
• Last Updated: December 10, 2021

Record last verified: 2021-12